Calcipotriene: Medgend

Calcipotriene FDA Approved Drugs

CALCIPOTRIENE [Calcipotriene^{C₂₇H₄₀O₃}]

0.005% (topical solution)

Fougera Pharms^{May 6, 2008}
G And W Labs Inc^{Mar 24, 2011}
Glenmark Pharms^{Jun 9, 2015}
Glenmark Pharms Inc^{Mar 24, 2010}
Hi Tech Pharma^{Nov 19, 2009}
Tolmar^{May 30, 2012}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE [Betamethasone Dipropionate^{C₂₈H₃₇FO₇} : Calcipotriene Hydrate^{C₂₇H₄₀O₃H₂O}]

0.064% : 0.005% (topical ointment)

Perrigo Israel^{Dec 12, 2014}
Tolmar^{Jan 14, 2013}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

DOVONEX [Calcipotriene^{C₂₇H₄₀O₃}]

0.005% (topical cream)

Leo Pharma As^{Jul 22, 1996}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

ENSTILAR [Betamethasone Dipropionate^{C₂₈H₃₇FO₇} : Calcipotriene^{C₂₇H₄₀O₃}]

0.064% : 0.005% (topical aerosol, foam)

Leo Pharma As^{Oct 16, 2015}

Plaque psoriasis.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

SORILUX [Calcipotriene^{C₂₇H₄₀O₃}]

0.005% (topical aerosol, foam)

Mayne Pharma^{Oct 6, 2010}

Use of a calcipotriene containing foam for the treatment of psoriasis.
Use of calcipotriene foam for the topical treatment of plaque psoriasis in patients aged 18 years and older.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

TACLONEX [Betamethasone Dipropionate^{C₂₈H₃₇FO₇} : Calcipotriene Hydrate^{C₂₇H₄₀O₃H₂O}]

0.064% : 0.005% (topical ointment)

Leo Pharma As^{Jan 9, 2006}

Psoriasis.
Treatment of moderate plaque psoriasis.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.

Ledgend of Medicine

MODERN MEDICINES

HOME REMEDIES

RANDOM DRUGS

RANDOM AILMENTS

Calcipotriene FDA Approved Drugs